Home » Aaron F. Barkoff
Aaron F. Barkoff
Aaron F. Barkoff is a patent attorney at McDonnell Boehnen Hulbert & Berghoff LLP, a law firm in Chicago. Aaron specializes in representing pharmaceutical and biotechnology companies. He is especially interested in issues that overlap between patent law and food & drug law, and he authors a weblog, Orange Book Blog, that reports on those issues.
Aaron F. Barkoff's Latest Articles
- Apotex Sues FDA to Recover Its 180-Day Exclusivity on Generic Plavix
- Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis Dismissed
- Validity of Takeda's Prevacid Patents Upheld; Teva's Obviousness Arguments Rejected
- Court Affirms Decision Protecting Ortho-McNeil's Topamax Against Mylan's Generic
- Federal Circuit Rules in Favor of Forest in Dispute with Caraco over Lexapro
- Eisai Wins Preliminary Injunction Against Teva's Generic Altheimer's Drug
- Court Sides with Amgen in European-Produced EPO Dispute with Roche
- Court Upholds P&G's Actonel Patent; Rejects Teva's Obviousness Arguments
- Pfizer's Latest-Expiring Patent on Celebrex Invalidated for Double Patenting
- Barr Labs Prevails Over Bayer in Yasmin Case
- Teva Trying to Assert Its Rights
-
Pfizer Victorious over Ranbaxy in Caduet Patent Litigation
on Dec 12, 2007 about PFE
- Teva's Nonenablement Argument Rejected as Court Finds Pfizer's Accupril Patent Valid
-
Court Dismisses Apotex's Cosopt Exclusivity Counterclaims Against Merck
on Nov 29, 2007 about MRK
- Bayer Prevails Over Dr. Reddy's in Avelox Case
- Invalidity of Par Pharma's Patents on Megestrol Acetate Formulations Affirmed by Federal Circuit Court
- Pfizer Wins Appeal in Neurontin Case
- Teva's Generic Famir Victory Overshadowed by Novartis' Emergency Injunction
- Aventis' Altace Patent Invalidated by Circuit Court
- Federal Circuit Court Denies Teva's Appeal of Forest Labs' Lexapro Patent
-
Pfizer: Lipitor Reissue Patent Application Rejected
on Aug 20, 2007 about PFE
-
Court Denies Validity of AstraZeneca's Toprol-XL Patent
on Jul 26, 2007 about AZN
- Merck's Formulation Patent on Pepcid Complete Invalidated by District Court
- Court Upholds Validity of AstraZenec's Prilosec Patents
- Denial of Certiorari in Tamoxifen Case Recommended by the Solicitor General
-
Court Opinion Explains Dismissal of Merck's Fosamax Suit
on May 24, 2007 about MRK
- Pfizer's Petition for Rehearing in Norvasc Case Denied
- Novartis' Temporary Restraining Order Halts Teva's Distribution of Lotrel
- FDA Decision on Pfizer's Norvasc Exclusivity Upheld
- Generics Challenge FDA's Decision On Pfizer Drug
-
Apotex Opposes Court Dismissal of Merck's Fosamax Suit
on Apr 26, 2007 about MRK
-
Court Affirms Invalidity of AstraZeneca Prilosec Process Patent
on Apr 24, 2007 about AZN
May 14, 2008
| Last Updated
07:47
ET
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Trading Center
- About Seeking Alpha
- About Us
- , Contact
- What's New
- Readers Feedback
- Tools & Widgets
- Stock Market Toolbar
- Stock Search Add-on
- Power Search
- Email Alerts
- Live Feeds (RSS)
- Legal
- Terms of Use
- Privacy
- Copyright
- Advertise
Want to talk to our community?
Got something interesting to say?
- Advertise with Us
Latest Commentson Aaron F. Barkoff's Articles